These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32291351)

  • 21. No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.
    Rogosnitzky M; Berkowitz E; Jadad AR
    JMIRx Med; 2020; 1(1):e19583. PubMed ID: 33724265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria.
    Karatzas E; Minadakis G; Kolios G; Delis A; Spyrou GM
    Comput Struct Biotechnol J; 2019; 17():939-945. PubMed ID: 31360332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning.
    Han L; Shan G; Chu B; Wang H; Wang Z; Gao S; Zhou W
    Cogn Neurodyn; 2023 Jun; 17(3):803-811. PubMed ID: 34777628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database.
    Korn D; Bobrowski T; Li M; Kebede Y; Wang P; Owen P; Vaidya G; Muratov E; Chirkova R; Bizon C; Tropsha A
    ChemRxiv; 2020 Jun; ():. PubMed ID: 32601612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience.
    Gozzo L; Longo L; Vitale DC; Drago F
    Front Pharmacol; 2020; 11():588132. PubMed ID: 33101042
    [No Abstract]   [Full Text] [Related]  

  • 26. Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages.
    Mangoni AA; Erre GL
    Ther Adv Drug Saf; 2021; 12():2042098621998876. PubMed ID: 33796258
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: Drug Repurposing for COVID-19 Therapy.
    Maldonado R; Drago F
    Front Pharmacol; 2021; 12():748886. PubMed ID: 34504433
    [No Abstract]   [Full Text] [Related]  

  • 28. Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8-11; 2021).
    Krishna S; Augustin Y; Wang J; Xu C; Staines HM; Platteeuw H; Kamarulzaman A; Sall A; Kremsner P
    Trends Parasitol; 2021 Apr; 37(4):357. PubMed ID: 33541791
    [No Abstract]   [Full Text] [Related]  

  • 29. A Database of Drug Repurposing Clinical Trials in Oncology.
    Pantziarka P; Vandeborne L; Bouche G
    Front Pharmacol; 2021; 12():790952. PubMed ID: 34867425
    [No Abstract]   [Full Text] [Related]  

  • 30. Study Aims to Identify Drugs That Could Be Repurposed for COVID-19.
    Rubin R
    JAMA; 2020 Nov; 324(20):2019. PubMed ID: 33231648
    [No Abstract]   [Full Text] [Related]  

  • 31. Correction for vol. 373, p.
    BMJ; 2021 May; 373():n1277. PubMed ID: 34020967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to: Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.
    Cheng J; Zhang J; Wu Z; Sun X
    Brief Bioinform; 2021 Mar; 22(2):1511-1512. PubMed ID: 33448287
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 database launched in the USA.
    Fyfe I
    Nat Rev Neurol; 2021 Mar; 17(3):132. PubMed ID: 33564186
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID-19.
    Sookaromdee P; Wiwanitkit V
    Arch Med Res; 2021 Jul; 52(5):572. PubMed ID: 33589286
    [No Abstract]   [Full Text] [Related]  

  • 35. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-cell atlas of the peripheral immune response to severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martinez-Colon GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    medRxiv; 2020 Apr; ():. PubMed ID: 32511639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell landscape of immunological responses in patients with COVID-19.
    Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
    Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
    Wen W; Su W; Tang H; Le W; Zhang X; Zheng Y; Liu X; Xie L; Li J; Ye J; Dong L; Cui X; Miao Y; Wang D; Dong J; Xiao C; Chen W; Wang H
    Cell Discov; 2020; 6():31. PubMed ID: 32377375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Eschweiler S; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    Cell; 2020 Nov; 183(5):1340-1353.e16. PubMed ID: 33096020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
    Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.